title: Safety of osteoanabolic therapy: a decade of experience.
authors.affiliation: Metabolic Bone Diseases Unit, Division of Endocrinology, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
authors.forename: Cristiana
authors.initials: C
authors.lastname: Cipriani
authors.forename: Cristiana
authors.initials: C
authors.lastname: Capriani
authors.forename: Dinaz
authors.initials: D
authors.lastname: Irani
authors.forename: John P
authors.initials: JP
authors.lastname: Bilezikian
mesh_terms: D045930:Anabolic Agents / Q000627:therapeutic use*; D000818:Animals; D001842:Bone and Bones / Q000378:metabolism; D002118:Calcium / Q000652:urine; D002986:Clinical Trials as Topic; D005260:Female; D017102:Fracture Healing / Q000187:drug effects; D050723:Fractures, Bone / Q000517:prevention & control*; D005938:Glucocorticoids / Q000009:adverse effects; D006801:Humans; D007011:Hypoparathyroidism; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced / Q000188:drug therapy; D012516:Osteosarcoma / Q000139:chemically induced; D010281:Parathyroid Hormone / Q000009:adverse effects / Q000627:therapeutic use*; D051381:Rats; D011916:Rats, Inbred F344; D019379:Teriparatide / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D045930:Anabolic Agents; D005938:Glucocorticoids; D010281:Parathyroid Hormone; D019379:Teriparatide; D002118:Calcium